focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,470.00
Bid: 1,470.00
Ask: 1,479.00
Change: 70.00 (5.00%)
Spread: 9.00 (0.612%)
Open: 1,413.00
High: 1,480.00
Low: 1,378.00
Prev. Close: 1,400.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Sep 2021 07:00

RNS Number : 3017K
Keywords Studios PLC
01 September 2021
 

1 September 2021

Keywords Studios plc ("Keywords Studios", "the Company")

 

Total Voting Rights

 

In accordance with DTR 5.6 of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTR"), the total number of ordinary shares of £0.01 each in the capital of the Company in issue as at the date of this notice is 75,819,989 with each share carrying the right to one vote.

The Company does not hold any shares in treasury. Therefore, the number of ordinary shares with voting rights is 75,819,989.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Financial Conduct Authority's DTR.

 

For further information, please contact:

 

Keywords Studios (www.keywordsstudios.com)

Jon Hauck, Joint Interim Chief Executive Officer

Sonia Sedler, Joint Interim Chief Executive Officer

Joseph Quinn, Investor Relations

+353 190 22 730

 

Numis Securities

Stuart Skinner/Kevin Cruickshank/Will Baunton

 

+44 20 7260 1000

 

MHP Communications (Financial PR)

Katie Hunt/James Midmer/Charles Hirst

 

 

+44 20 3128 8193

keywords@mhpc.com

About Keywords Studios (www.keywordsstudios.com)

Keywords Studios is an international technical services provider to the global video games industry. Established in 1998, and now with over 65 facilities in 23 countries strategically located in Asia, Australia, the Americas and Europe, it provides integrated art creation, marketing services, game development, testing, localization, audio and player support services across more than 50 languages and 16 games platforms to a blue-chip client base of over 950 clients across the globe.

Keywords Studios has a strong market position, providing services to 23 of the top 25 most prominent games companies, including Activision Blizzard, Bandai Namco, Bethesda, Electronic Arts, Konami, Microsoft, Riot Games, Square Enix, Supercell, TakeTwo, Epic Games and Ubisoft. Recent titles worked on include Call of Duty: Black Ops Cold War, Anthem, Star Wars Jedi: Fallen Order, Assassin's Creed Valhalla, Valorant, League of Legends, Fortnite, Clash Royale and Doom Eternal. Keywords Studios is listed on AIM, the London Stock Exchange regulated market (KWS.L).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANPFDFAFEFA
Date   Source Headline
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase
8th Jun 20232:42 pmRNSHolding(s) in Company
1st Jun 20233:53 pmRNSTotal Voting Rights
26th May 20232:55 pmRNSResult of AGM
24th May 20234:06 pmRNSDirector/PDMR Shareholding
23rd May 20233:34 pmRNSIssue of Shares
23rd May 20231:45 pmRNSHolding(s) in Company
22nd May 20234:10 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSBlock listing return
15th May 20237:00 amRNSPassing of Ross Graham and Chairman Succession
11th May 20234:45 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAcquisition
9th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 20234:49 pmRNSTotal Voting Rights
18th Apr 20239:46 amRNSBlock Admission
17th Apr 20237:00 amRNSPublication of Annual Report and Accounts
3rd Apr 20239:59 amRNSTotal Voting Rights
3rd Apr 20238:56 amRNSIssue of Shares
31st Mar 202312:11 pmRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAcquisition
15th Mar 20237:00 amRNSFinal Results
9th Mar 20233:32 pmRNSIssue of Shares
1st Mar 20234:56 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSTotal Voting Rights
13th Feb 20231:38 pmRNSIssue of Shares
1st Feb 20237:01 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSAcquisition
25th Jan 20237:00 amRNSFull Year Trading Update
19th Jan 20237:00 amRNSDirectorate Change
16th Jan 20232:16 pmRNSHolding(s) in Company
12th Jan 202312:17 pmRNSIssue of Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20229:00 amRNSAcquisition
13th Dec 20227:00 amRNSAcquisition
9th Dec 20225:02 pmRNSDirector/PDMR Shareholding
8th Dec 20224:52 pmRNSDirector/PDMR Shareholding
7th Dec 202210:57 amRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition
1st Dec 20227:00 amRNSTotal Voting Rights
21st Nov 20223:00 pmRNSIssue of Shares
21st Nov 20227:00 amRNSTrading Update
14th Nov 20227:00 amRNSBlock Listing Return
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20222:30 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSAppointment of Chief Operating Officer Designate
21st Oct 20227:00 amRNSBlock Admission
19th Oct 20227:00 amRNSIssue of Shares
6th Oct 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.